Cargando…
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Overall, 12% of the global population (800 million) suffers from liver disease, which causes 2 million deaths every year. Liver injury involving characteristic reactive oxygen/nitrogen species (RONS) and inflammation plays a key role in progression of liver disease. As a key metabolic organ of the h...
Autores principales: | Liu, Min, Huang, Qiong, Zhu, Yan, Chen, Li, Li, Yumei, Gong, Zhicheng, Ai, Kelong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850330/ https://www.ncbi.nlm.nih.gov/pubmed/35198963 http://dx.doi.org/10.1016/j.mtbio.2022.100215 |
Ejemplares similares
-
Nanomaterial-based biosensor developing as a route toward in vitro diagnosis of early ovarian cancer
por: Yang, Yuqi, et al.
Publicado: (2022) -
Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy
por: Huang, Jia, et al.
Publicado: (2022) -
A photodynamic-mediated glutamine metabolic intervention nanodrug for triple negative breast cancer therapy
por: Yu, Cancan, et al.
Publicado: (2023) -
Ignored role of polyphenol in boosting reactive oxygen species generation for polyphenol/chemodynamic combination therapy
por: Mao, Huijia, et al.
Publicado: (2022) -
Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19
por: Chen, Li, et al.
Publicado: (2021)